Wei et al. performed scRNA-seq on Bcl9-depleted or Bcl9-inhibited tumor samples, revealing that Bcl9 inhibition suppresses endothelial cell differentiation into extracellular matrix cells, thereby impairing angiogenesis and tumor vascularization [64]. The gene discussed is BCL9; the disease is neoplasm.